Beylot-Barry, Marie <br/><br/>
A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type.  [electronic resource] 

 -  The Journal of investigative dermatology  09 2018 
 - 1982-1989 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1016/j.jid.2018.03.1516  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biopsy<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>France--epidemiology<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Leg<br/>Lenalidomide--administration & dosage<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Neoplasm Recurrence, Local<br/>Remission Induction<br/>Skin--pathology<br/>Skin Neoplasms--drug therapy<br/>Survival Rate--trends<br/>Treatment Outcome